NA Proactive news snapshot: NexTech AR, DGTL Holdings, Power Ore, Gevo UPDATE …

  NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) revealed second-quarter revenue after the bell Tuesday that more than doubled year-over-year as demand for its InfernoAR video conferencing platform surged. The augmented reality company brought in C$3.5 million during the three months ended June 30, a 133% increase from the same period of 2019. Gross profit jumped 171% to C$2.1 million. A major driver of the swelling revenue was the company's newly launched InfernoAR business, which has booked approximately C$1 million in virtual event deals over the past 60 days. DGTL Holdings Inc (CVE:DGTL) provided investors with an update Tuesday on the progress of its subsidiary Hashoff LLC, a full-service content management firm, with clients including Anheuser-Busch InBev (NYSE:BUD). Hashoff is a self-service Content-as-a-Service (CaaS) company built on proprietary artificial intelligence and machine learning (AI-ML) technology. Its content management system empowers global brands by identifying, optimizing and tracking top-ranked media content publishers for localized brand marketing campaigns. For Anheuser-Busch, Hashoff’s campaigns have executed or are currently executing 21 brand activations, more than 5 million content engagements, more than 1,500 new pieces of content and a 5.43% average user engagement rate. Power Ore Inc (CVE:PORE) has closed a non-brokered private placement for aggregate proceeds of $985,000. The private placement was oversubscribed. The company offered 5,184,333 Flow-Through Units at $0.09 per unit for gross proceeds of $466,589.98, where each FT Unit consists of one flow through common share and one half of one common share purchase warrant. Each whole warrant will entitle the holder to purchase one additional common share of the company at $0.14 for a period of 24 months from the date of issuance. It offered \some 6,912,134 Non Flow-Through Units at $0.075 per unit for gross proceeds of $518,410.02, where each Hard Dollar Unit consists of one common share and one half of one common share purchase warrant. Each whole warrant will entitle the holder to purchase one additional common share of the company at a price of $0.14 for a period of 24 months from the date of issuance. Gevo Inc (NASDAQ:GEVO) has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 38,461,545 shares of common stock at a purchase price of $1.30 per share. HC Wainwright & Co acted as the exclusive placement agent for the offering. After deducting the placement agent’s fees and other offering expenses payable by Gevo, the company received net proceeds of approximately $46.1 million. Gevo intends to use the net proceeds from the offering to fund working capital and for general corporate purposes, which may include the repayment of outstanding indebtedness. Media Central Corporation (CSE:FLYY) is relaunching the sale of adult classified ads in its Toronto-based NOW Magazine, a move the company expects to bring in more than $2 million annually. The decision comes as cities begin to reopen amid the coronavirus (COVID-19) pandemic and follows a similar decision by another Media Central publication, the Vancouver alt-weekly Georgia Straight. “In 2018, we stopped offering classifieds in the adult entertainment category because of stifling provincial legislation," NOW editor Kevin Ritchie said. "This year, Ontario Justice Thomas McKay struck down the ban on advertising sexual services, again allowing sex workers a right to promote their services." BioLargo Inc (OTCQB:BLGO) has unveiled that the first municipal wastewater trial of its water treatment technologies will take place at a treatment plant new Montréal in Québec, with experts in water treatment and technology development from the Centre des Technologies de L'Eau (CTE) to supervise and validate the performance of the pilot on-site.  Loop Insights Inc (CVE:MTRX) (OCTMKTS:VRZPF), a provider of contactless solutions and artificial intelligence to drive automated marketing, said Tuesday that it had inked a partnership agreement with KABN System NA Holding Corp’s (CSE:KABN) fintech subsidiary KABN Systems North America Inc, which specializes in online identity verification. The new partners will create a verified digital check-in system for large venues. As more check-ins are required for contact tracing purposes, KABN NA can enhance Loop's contact tracing check-in solution with its proprietary blockchain technology. Loop said KABN’s Liquid Avatar program will boost security within Loop's services as customer information will be protected by blockchain technology. Loop said the identity verification enhancement will help it to tap “large opportunities” with schools, stadiums, and governments that are reopening and need “fast and secure” contact tracing check-in platforms. Progressive Planet Solutions Inc (CVE:PLAN), an emerging leader in the commercialization of natural pozzolans to reduce the carbon footprint of cement production, has announced two financings for aggregate gross proceeds of up to $467,500. In a statement Tuesday, PLAN said the first financing consists of a non-brokered private placement of up to 3.5 million units at $0.065 each, for gross proceeds of up to $227,500. Each such unit will consist of one share and one half warrant exercisable at $0.10 per share for a period of 12 months from issuance. The second financing consists of a non-brokered flow-through private placement of up to 3 million units at $0.08 apiece, for gross flow through proceeds of up to $240,000.  Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) posted second-quarter financial results on Tuesday that showed revenue grew 56% on the back of record patient growth at the company’s Sun Valley Health subsidiary, which owns a network of physician-staffed, health & wellness clinics in Oregon and Arizona. For the period ended June 30, 2020, the group clocked up revenue of $923,876 driven by 6,696 patient visits, compared to revenue of $591,023 based on 1,198 patient visits in the first quarter of 2019. The group substantially lowered its net loss to $401,110 or $0.00 per share in the second quarter, compared to $1,456,506 or $0.01 per share for the same period in 2019 by reducing operating costs through aggressive headcount cuts, facility changes and a reduction in legal fees. Mind Medicine (MindMed) Inc (NEO:MMED) (OTCQB:MMEDF) and the University Hospital Basel's Liechti Lab will combine MDMA and LSD in a groundbreaking Phase 1 clinical trial.  The MDMA-LSD trial, the first-ever to combine both drugs, is scheduled to start in the fourth quarter in Basel, Switzerland, MindMed said in a statement Tuesday.  New York-based MindMed said that combined MDMA-LSD treatments have the potential to create next-generation psychedelic-assisted therapy paradigms. When added to a psychedelic-assisted therapy session, MDMA has the potential to reduce some known rare negative side effects that may occur while using LSD or other classic psychedelics on their own, MindMed noted.   Falcon Gold Corp (CVE:FG) has bolstered its portfolio by acquiring the Springpole West property, which lies in the Red Lake area of Ontario and is next to First Mining Gold Corp's (TSE:FF) Springpole gold deposit. The asset spans 4,440 hectares and comprises 197 claims, the most northeastern of which lie less than 4 kilometres (km) from the First Mining deposit. The project covers 13.5km of strike and previous work has indicated significant gold and silver values at surface and at depth. Trillion Energy International Inc (CSE:TCF) (OTCMKTS:TCFF) said the recent discovery of the largest potential natural gas discovery in the Black Sea near to its own SASB gas field augurs well for the oiler's own asset. The discovery named the Tuna-1 field, which was formally announced on August 21, was made in the western portion of the Black Sea by the Turkish national petroleum company (TPAO), Trillion's partner in the SSAB field. The Tuna-1 well, which lies around 100 kilometres south of SASB, encountered 100 metres of pay at a total depth of 3,520 meters and Turkish officials estimated 9 trillion cubic feet (TCF) of gas based on the current drilling, noted Trillion. EXMceuticals Inc (CSE:EXM) (FSE:A2PAW2) said it has made advancements in the research & development (R&D) operations at its facility in Lisbon, Portugal. The bioscience firm, which specializes in unique cannabinoid formulations, said it has applied for a P2020 research grant under the project name SkanABility for a proof-of-concept study of the biological activity of cannabinoids and terpenes in cosmeceutical applications. The firm also said it has recently submitted an application to the Portuguese government through the I&D COVID-19 initiative and has begun investigating the virucidal efficacy of cannabis and terpene molecules in combatting the coronavirus. NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) has hired SAP executive and artificial intelligence expert Eugen Winschel to be its new chief operating officer, the company announced Tuesday.  Winschel spent 18 years at SAP, the German multinational software company, most recently as its global vice president. While there, he worked to develop an enterprise AI solution using machine learning and ran multiple corporate-wide growth and efficiency initiatives. “The NexTech board is thrilled to have Eugen join the company, and I am beyond excited to have him join the NexTech family at this pivotal time of our rapid growth stage,” CEO Evan Gappelberg said in a statement. Phunware Inc (NASDAQ:PHUN) said it has added a new ‘big four’ customer for its mobile corporate campus solution, a multiscreen-as-a-service (MaaS) which allows employers to increase productivity and satisfaction. The mobile cloud platform specialist said the new international intends to use its MaaS to manage room bookings, enable positioning, wayfinding and navigation throughout its facilities, enable location sharing amongst its employees, partners and customers and extend its other building services via mobile integration and activation. Phunware noted that platform integrations with existing third-party solutions will also support additional services, including parking management, food ordering, asset tracking, interactive directories, fitness access, security and user feedback. Newgioco Group Inc (NASDAQ:NWGI) announced Tuesday that it achieved a top-five market share in the Italian online poker market, according to industry publication Agenzia Giornalistica sul Mercato del Gioco (AGIMEG). The AGIMEG report, which relies on data from Italian regulators, showed Newgioco as having a 5.56% market share, the fifth-highest of nearly 30 operators in the country. Newgioco’s Italian operations include alternative online wagering services, resort concept casinos, retail neighborhood betting establishments and franchise distribution networks. Klondike Gold Corp (CVE:KG) (OTCPINK:KDKGF) said Tuesday that it plans to raise as much as C$2.5 million in a non-brokered private placement to fund continued exploration and development of its Yukon properties. The placement is divided into flow-through shares (a type of common share which allows the company to incur eligible exploration expenses up to the amount paid by the buyer) and normal common shares.  The flow-through shares will be offered at a price of C$0.30 per unit, with each unit containing one share and one-half a share purchase warrant. The normal shares will go for C$0.25 per unit.  Helix Technologies Inc (OTCQB:HLIX) announced Tuesday that New Mexico's online medical marijuana reciprocity portal is live and has been serving out of state patients living or vacationing in New Mexico. The system, which is the first of its kind for US Medical Cannabis programs, allows state regulators to electronically register and track out of state patients into the patient registry. The system decreases time and costs associated with paper only patient registries and allows the state to track and enforce dispensing limits in real-time to prevent potential diversion to the black market. Antibe Therapeutics Inc (CVE:ATE) (OTCQB:ATBPF) has revealed it plans to file an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for its lead drug otenaproxesul, formerly known as ATB-346, within the next six months, to allow for Phase 3 clinical trials in the US. The news accompanied the Toronto-based biotech's posting of its fiscal first-quarter results to end-June, 2020. Otenaproxesul is targeting the global need for a safer, non-addictive drug for chronic pain and inflammation. In successful Phase 2 trial results, released in June this year, both 250 mg and 200 mg doses of ATB-346 showed superiority to placebo in reducing pain with a high level of statistical significance. XPhyto Therapeutics Corp (CSE:XPHY) (OTCPINK:XPHYF) offered investors an update on its transdermal delivery system for the neurologic drug Rotigotine saying the “formula was locked” and the company is looking forward to clinical studies in the third quarter of 2020. Vancouver-based XPhyto Therapeutics first revealed in June that its German subsidiary Vektor Pharma TF GmbH had finalized the formula for its skin patch to help Parkinson's disease sufferers ahead of human pilot studies. According to the company, Vektor Pharma has now completed process implementation for the manufacture of its Rotigotine patches. “With process implementation complete, clinical sample manufacturing and analytical work will commence in Vektor’s EU GMP laboratory and manufacturing facility based in Baden-Württemberg, Germany,” it said. Globex Mining Enterprises Inc (TSX:GMX) (OTCMKTS:GLBX) told shareholders Tuesday that it has closed on two additional property deals to raise $1.7 million in cash. In the first case, the company said it has sold its 100% interest in all 16 cell fractions of the Sigma East Property and one cell fraction of the Sigma 2 property, to Eldorado Gold Quebec Inc, a subsidiary of Eldorado Gold Corporation (NYSE:EGO), for a single cash payment of C$1.6 million. In the second disposal, the company said it sold six cells in the Windfall mining camp to Osisko Mining Inc (TSX:OSK). One of the Windfall area cells is on strike and to the east of Osisko’s Windfall gold deposit, three are further southeast and off the main structure, and two are near to the southwest and on strike of the Black Dog gold deposit.  In exchange for the cells, Osisko has paid Globex $100,000 in cash. Globex said it has retained a 2% gross metal royalty. Tocvan Ventures Corp (CSE:TOC) has welcomed the initial findings of a structural analysis of its Pilar gold-silver project in Sonora, Mexico, which show the site could host a world-class discovery. Major large geological structures, which could be seen as potential 'plumbing' for a deposit, with significant depth containing additional structures favorable for gold-silver mineralization have been identified, the firm told investors. Initial work showed a large structure trending northwest (NW) to southeast (SE) with dimensions of around 250 metres (m) by 1000m with vertical extents measured in multiple 100's of metres extending to surface. Co-Diagnostics, Inc. (NASDAQ:CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, has said its CEO Dwight Egan will be discussing the company’s significant growth, profitability, and future objectives at HC Wainwright’s 22nd Annual Global Investment Conference on Monday, September 14, 2020, at 10.00am ET. Egan will provide a recap of the company’s financial, scientific, and regulatory accomplishments in the context of the ongoing global coronavirus health crisis, as well as outline how Co-Diagnostics expects to remain a leader in cutting edge molecular diagnostics solutions. Egan commented:  ”Co-Diagnostics has been at the forefront of the battle against the coronavirus since January, and our innovative design platform and patented CoPrimer technology have allowed us to stand out and enabled our rapid rise to impressive sales and profitability.” He added: “We believe both our outstanding financial and scientific achievements, as well as our regulatory authorizations by the US FDA, India, European Community and others, and our expanded distributor network covering nearly 50 countries and over 25 states have all positioned the Company for extraordinary future growth.” More information about the HC Wainwright conference, which will be held virtually, can be found here: https://www.meetmax.com/sched/event_61861/conference_home.html AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) announced that it will be presenting at The LD 500 Investor conference being held virtually on September 1-4, 2020. Thomas K. Equels, the chief executive officer of AIM ImmunoTech, is scheduled to present on Tuesday, September 1, 2020, at 1.20pm Eastern Time. The presentation will be webcast live on the conference event platform, which can be accessed here: https://www.webcaster4.com/Webcast/Page/2019/36116. One-on-one meetings will be held throughout the conference via video conference calls. To register for the conference, contact David Scher at david@ldmicro.com or visit https://ld-micro-conference.events.issuerdirect.com/. Nemaura Medical, Inc. (NASDAQ:NMRD), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT, its non-invasive and flexible continuous glucose monitor (CGM), together with BEATdiabetes, a planned health subscription service designed to help people with Type 2 diabetes and prediabetes through personalized lifestyle coaching, announced that its CEO Dr Faz Chowdhury will be presenting at the LD 500 investor conference on Thursday, September 3, 2020, at 10,20am ET. In the presentation, Dr Chowdhury will provide insight into the company’s progress on product rollouts in the USA, Germany and UK, as well as the use of its CGM and lactate monitoring solutions for monitoring of disease progression in coronavirus (COVID-19) patients. Interested investors can register here: https://ld500.ldmicro.com/ Algernon Pharmaceuticals Inc. (CSE:AGN) (OTCQB:AGNPF), a clinical-stage pharmaceutical development company, has said that it will be providing an update on its Ifenprodil idiopathic pulmonary fibrosis (IPF) and chronic cough Phase 2 human study, presented by Dr Mark Williams, CSO and special guest panellist Dr Martin Kolb. Dr Kolb is a leading global scientific expert and clinician in the area of IPF and is the Moran Campbell Chair, Professor in Respiratory Medicine and Director of the Division of Respirology, McMaster University, Hamilton, Ontario, Canada. The BioPub webcast will be held Wednesday, August 26, 2020, hosted by Dr KSS at 12.00pm EDT. BioPub has been analyzing small-cap special situation biotech investments for 7 years to readers in over 40 countries. Interested shareholders, investors, members of the media and the public to listen to the interview free of charge via the webinar link: https://us02web.zoom.us/j/85700905505, Webinar ID: 857 0090 5505; or by iPhone one-tap: US +13017158592, 85700905505# or +13126266799, 85700905505#Or; or by telephone: US: +1 301 715 8592  or +1 312 626 6799  or +1 346 248 7799  or +1 646 558 8656  or +1 669 900 9128  or +1 253 215 8782; International numbers available: https://us02web.zoom.us/u/kkHi2pq1W WeedMD Inc. (CVE:WMD) (OTCQX:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical-grade cannabis, has announced that its chief executive officer, Angelo Tsebelis, and its chief commercial officer Stephen Ng will be presenting virtually at the following upcoming conferences: The LD 500 Virtual Conference on Tuesday, September 1, 2020, at 11.20am. ET; and the HC Wainwright & Co. 22nd Annual Global Investment Conference on Wednesday, September 16, 2020, at 3.00pm ET. Information about upcoming corporate events including conference access and replays, where applicable, can be found here: https://www.weedmd.com/investor-events/ Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, has said it will participate in two investor conferences during the month of September 2020 - the LD 500 Virtual Investor Conference on September 1-4, 2020, and the HC Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020. Calyxt chief executive officer, Jim Blome and its chief financial officer, Bill Koschak are scheduled to host a virtual presentation during the conferences and will also participate in one-on-one meetings throughout the day. LD 500 Virtual Investor Conference on Wednesday, September 2, 2020, at 12.40pm Eastern time (9.40am Pacific time) via webcast link: https://www.webcaster4.com/Webcast/Page/2019/36175. HC Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16, 2020at 3.00pm Eastern time via webcast link: https://ir.calyxt.com/news-events BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, has announced that it will be presenting at the LD 500 Investor Conference on Tuesday, September 1, 2020, at 8.00am PST / 11.00am EST. BioLargo President & CEO Dennis P. Calvert will be presenting to a live virtual audience of prospective investors. A major focus of his presentation will be Clyraguard Personal Protection Spray. BioLargo's subsidiary Clyra Medical Technologies recently launched Clyraguard, a safe, effective, FDA-registered disinfectant for use on personal protection equipment (PPE) like facemasks. The company is currently ramping up distribution and sales of the new product through agreements with several contract manufacturers and a major national healthcare products distributor. Calvert will also discuss the company's per- and polyfluoroalkyl substance (PFAS) treatment technology, the BioLargo AEC, which is expected to begin its first pilots and commercial trials in late 2020 and early 2021. PFAS are a persistent and widespread class of contaminants of emerging concern globally due to their ability to cause serious health problems in humans and because of the difficulty with which they are removed from water. The BioLargo AEC has been proven capable of 99%+ PFAS removal from water in continuous flow and expects to be a low-cost high-efficiency solution for industry. Investors can register for the event via the following link: https://ld500.ldmicro.com/ BioSig Technologies, Inc. (NASDAQ:BSGM), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals,  announced that it will be presenting at the 12th Annual LD 500 Conference on Wednesday, September 2, 2020, at 11.40am ET.  It said Kenneth L. Londoner, the chairman and CEO of BioSig Technologies, will present virtually to an online audience. The company will provide updates about its recent developments and key highlights, including progress with PURE EP system installations. BioSig recently installed its PURE EP System at Massachusetts General Hospital (MGH) as part of an expanding clinical study. BioSig’s subsidiary, ViralClear Pharmaceuticals, Inc., is currently enrolling patients into its Phase 2 clinical study of merimepodib in combination with remdesivir in adult patients with advanced coronavirus (COVID-19). Investors can register here: https://ld-micro-conference.events.issuerdirect.com/. Webcast address: https://www.webcaster4.com/Webcast/Page/2019/36166 Medexus Pharmaceuticals Inc. (CVE:MDP) (OTCQX:PDDPF) has announced that due to public health restrictions related to the coronavirus (COVID-19) pandemic, its annual general meeting will be held virtually by live webcast - at https://web.lumiagm.com/455381759 - on Thursday, September 17, 2020, at 9.30am Eastern Time. The meeting can be accessed through the following link: https://web.lumiagm.com/455381759 in a web browser; Password: medexus2020 (case sensitive) The company also announced that its board has approved the issuance of an aggregate of 49,365 restricted share units (RSUs) to its non-executive directors under the company’s 2018 omnibus equity incentive plan. Each vested RSU entitles the holder to receive one common share of the company. Medexus also announced that it will be presenting at the LD 500 Investor conference being held virtually on September 1-4, 2020. Ken d'Entremont, chief executive officer of Medexus, and Roland Boivin, its chief financial officer are scheduled to present on Tuesday, September 1, 2020, at 11.40am Eastern Time. The presentation will be webcast live on the conference event platform, which can be accessed here: https://www.webcaster4.com/Webcast/Page/2019/36084. One-on-one meetings will be held throughout the conference via video conference calls. Zinc8 Energy Solutions Inc. (CSE:ZAIR) has announced the resignation of Lyndon Patrick from its board of directors effective immediately. The group said: "We want to thank him for his time spent serving on the Board and wish him success in his future endeavors." Current Zinc8 Board members consist of Ron MacDonald, Michael Reimann and David Hodge. Ximen Mining Corp (CVE:XIM) said the TSX Venture Exchange has accepted for filing documentation with respect to the second and final tranche of its non-brokered private placement announced August 19, 2020., which will see the issue of 454,545 shares at a purchase price of 52 cents per share, together with 454,545 share purchase warrants with an exercise price of 81.25 cents for a three-year period, with one placee. Jay Taylor, in the August 14, 2020, edition of Gold, Energy & Tech Stocks, has refreshed his buy of Benchmark Metals Inc. (CVE:BMK) recently $1.44. Taylor has said buy three times from July 16, 2019, to July 16, 2020, at prices ranging from 31.5 cents to 65 cents. Assuming a $1,000 investment for each of the three buys, the $3,000 position is now worth $10,297. Benchmark is currently drilling its Lawyers gold-silver project in north-central British Columbia. The most recent highlight of the drill program, announced Aug. 5, was a 57.91-metre intersection grading 1.90 grams per tonne gold and 91.96 g/t silver, or 3.05 g/t gold equivalent (AuEq). This included a 33.53-metre subinterval of 5.07 g/t AuEq. In addition to the encouraging lengths and grades, the hole indicated that mineralization begins at surface and remains open in all directions. This bodes well for Benchmark's focus on expanding and defining new mineral resources. "I think something big is starting to unfold for Benchmark," Taylor said. He is looking forward to an updated resource estimate in early 2021 and a preliminary economic assessment later that year. OTC Markets Group Inc. (OTCQX:OTCM), the operator of financial markets for 11,000 US and global securities, has announced that TriStar Gold Inc. (CVE:TSG;) (OTCQX:TSGZF), a junior exploration and development company focusing on gold properties in the Americas, has qualified to trade on the OTCQX Best Market and has upgraded today from the OTCQB Venture Market. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among US investors. Nicholas Appleyard, president and CEO commented: "We are extremely pleased to be elevated to trading on OTCQX as we believe that OTCQX provides a superior trading platform for the foreign and US investors in TriStar Gold and that OTCQX complements the Company's trading on the Toronto Venture Exchange."